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Objectives. Our objectives were to identify and define a mini-
mum set of variables for interventional cardiology that carried the
most statistical weight for predicting adverse outcomes. Though
“gaming” cannot be completely avoided, variables were to be as
objective as possible and reproducible and had to be predictive of
outcome in current databases.
Background. Outcomes of percutaneous coronary interventions
depend on patient risk characteristics and disease severity and
acuity. Comparing results of interventions has been difficult
because definitions of similar variables differ in databases, and
variables are not uniformly tracked. Identifying the best predictor
variables and standardizing their definitions are a first step in
developing a universal stratification instrument.
Methods. A list of empirically derived variables was first tested
in eight cardiac databases (158,273 cases). Three end points
(in-hospital death, in-hospital coronary artery bypass graft sur-
gery, Q wave myocardial infarction) were chosen for analysis.
Univariate and multivariate regression models were used to
quantify the predictive value of the variable in each database. The
variables were then defined by consensus by a panel of experts.
Results. In all databases patient demographics were similar,
but disease severity varied greatly. The most powerful predictors
of adverse outcome were measures of hemodynamic instability,
disease severity, demographics and comorbid conditions in both
univariate and multivariate analyses.
Conclusions. Our analysis identified 29 variables that have the
strongest statistical association with adverse outcomes after cor-
onary interventions. These variables were also objectively defined.
Incorporation of these variables into every cardiac dataset will
provide uniform standards for data collected. Comparisons of
outcomes among physicians, institutions and databases will there-
fore be more meaningful.
(J Am Coll Cardiol 1998;32:275–82)
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Comparison of outcomes of coronary interventions from dif-
ferent medical centers requires consideration of the risk
characteristics of the different patient populations served as
well as the severity and acuity of the disease itself (1–3). In
addition, accurate evaluation of the anticipated risk of a
procedure is essential for planning treatment strategies (4).
Comparing the results obtained in various databases (1,5–9)
has been difficult because the definitions of seemingly similar
variables differ (3), and the variables are not uniformly tracked.
Standardizing variable definitions as well as identifying vari-
ables that carry most of the statistical weight in the analysis
would be an important first step in developing a minimum
dataset. This principle has been developed for cardiac surgery
by Jones et al. (10). This report identifies a standardized
stratification instrument that should be captured by databases
designed to assess performance of catheter-based coronary
interventions.
Methods
A working group with expertise in epidemiology, biostatis-
tics and coronary interventions was convened to develop and
define a list of variables relevant to coronary interventional
procedures. Variables to be tested were proposed by the
participants on the basis of empirical results from individual
databases and knowledge of published scientific reports.
Databases used. Eight databases ranging in size from 2,431
to 66,358 cases were used for this analysis (Table 1). Five of the
eight databases were single- or multi-institutional clinical
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databases including all types of coronary interventional cases
performed between 1990 and 1996. The National Heart, Lung,
and Blood Institute (NHLBI) database was a multi-institution
registry performed during 1985 to 1986. The New Approaches
to Cardiac Intervention (NACI) Registry database was a
multi-institutional clinical registry that included cases involving
newer coronary interventional device technologies other than
conventional balloon angioplasty only. The Cooperative Car-
diac Project (CCP) database was a multi-institutional database
limited to patients $65 years undergoing coronary interven-
tional procedures. In total, our final analysis dataset included
158,273 cases.
Definition of variables. Whenever possible, variables were
defined similarly to those used in the Cooperative CABG
[coronary artery bypass graft surgery] Database Project (10).
For the remainder, definitions were developed by consensus of
the working group. Definitions were written to be objective in
an effort to minimize “gaming.” Nevertheless, variables for
potential subjective interpretation include unstable angina,
Canadian Cardiovascular Society (CCS) class, congestive fail-
ure and urgency of the procedure. Three end points were
chosen: 1) In-hospital death (death within the same hospital
period from any cause after a coronary interventional proce-
dure). “Cardiac death” was considered but is more subjective,
leading to possible “gaming” (11). 2) In-hospital CABG (any
CABG during the same hospital period as the coronary
intervention). This end point includes “elective” CABG done
after an intervention. 3) Q wave myocardial infarction (MI)
(new Q waves in two contiguous electrocardiographic leads
and a twofold increase in serum creatine kinase levels within
the same hospital period as the coronary intervention). Non–Q
wave MI was not used because of the wide variability of
definitions for this entity in existing databases.
Within each database attempts were made to match existing
variable definitions to those set forth by the working group. If
a database manager considered that a database variable defi-
nition differed significantly, it was not included in the analysis.
The availability of predictor variables varied among databases.
Missing data were handled by sites in one of two ways: If the
variable was missing in .50% of cases within a database, it was
deleted from analysis. If the variable was missing in a minority
of cases, it was imputed to the median for continuous variables
and the lowest risk category for categoric data (e.g., missing
ejection fractions at Duke were replaced with a score of 56 [the
median ejection fraction for the Duke data], whereas missing
comorbid variables [e.g., renal insufficiency] were imputed to
the “none” level). These imputation methods are conservative
and tend to underestimate the predictive power of a variable.
For outcomes, all databases had information on in-hospital
death and CABG; only four had information on in-hospital Q
wave MI. We also tested whether a variable’s effect on
outcome varied among the eight data sources using a standard
test for homogeneity (12).
Univariate analysis. The first step was to construct univar-
iate logistic regression models predicting each of the three
outcomes. Each database reported univariate coefficients and
standard errors for each variable. To consolidate this large
amount of information, these estimates were then combined
using meta-analytic methods. The databases were indepen-
dently analyzed, and then pooled odds ratios from these
analyses were developed. Specifically, using a random-effects
empirical Bayes methodology model, we calculated a “pooled
estimate” for the univariate odds ratio and the confidence
interval surrounding these point estimates. This random-
effects model provides a more conservative estimate of a
variable’s effect on outcome (13,14).
Multivariate analysis. Because many of the candidate vari-
ables describe similar aspects of the patients’ disease, multi-
variate logistic regression models were next used to distinguish
between “competing” specifications of risk. Each database was
asked to place all the variables it had collected into a “full”
model and report the coefficients and standard errors for each
variable. After fitting this model, each database used an
automated stepwise selection algorithm to fit a smaller “step-
wise” model that contained only variables significant at an
alpha level of 0.05. Finally, to better assess the discrimination
abilities of the variables in question, the C-index or area under
the ROC curve was computed for each full and stepwise
multivariate model (15).
Abbreviations and Acronyms
CABG 5 Coronary artery bypass graft surgery
CCP 5 Cooperative cardiac project
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Databases Used For Analyses
Database (acronym)
Duration of
Study (yr)
No. of
Pts Description
National Cardiovascular
Network (NCN)
1994–96 66,358 Multicenter registry
National Heart, Lung and
Blood Institute Coronary
Angioplasty Registry
(NHLBI)
1985–86 2,431 Multicenter registry
New Approaches to Coronary
Intervention Registry
(NACI)
1990–94 3,561 Multicenter registry
(new devices only)
New York State Cardiac
Database (NY)
1994 18,558 Multicenter registry
Society for Coronary
Angiography and
Intervention Registry
(SCAI)
1993–95 31,455 Multicenter registry
Duke Cardiovascular
database (Duke)
1991–95 9,462 Single-center registry
Northern New England
Cardiac database (NNE)
1987–96 23,252 Multicenter registry
Cooperative Cardiac Project
database (CCP)
1994–95 3,196 Multicenter registry
(pts $65 yr old)
Pts 5 patients.
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As part of an international conference to further the
development of data standards held in Bethesda, Maryland on
June 27 to 28, 1996, the variables were reviewed to create
explicit, objective definitions of each variable by consensus.
Results
Baseline demographics, disease severity and comorbidity
characteristics of the 158,273 cases entered into the eight
databases are shown in Table 2. Patient demographics were
similar, but disease severity varied greatly among databases
(e.g., the proportion of patients with triple-vessel disease
ranged from 9.6% to 17.5%, acute MI within 24 h from 0.7%
to 12.4% and congestive failure from 4.0% to 14.7%). Signif-
icant variability existed among the more subjectively defined
variables (e.g., the frequency of unstable angina at the time of
procedure varied from 9.6% to 71.8%, and procedures classi-
fied as “urgent” varied from 2.0% to 43.1%). For the three
outcomes, overall rates were similar across databases (Table
3). The one exception to this was a generally higher event rate
Table 2. Baseline Characteristics
Variable
Overall
Weighted Mean
Minimum
Site
Maximum
Site
Median age (yr) 62.2 58.0 71.0
Gender (% male) 68.1 57.0 74.5
Median height (cm) 171.5 170.0 173.0
Median weight (kg) 80.5 77.0 82.0
Race/ethnicity
Black 4.0 4.4 11.0
White 91.6 85.0 95.1
Other 2.0 0.2 4.2
Median LVEF 56.7 51.0 60.0
No. of vessels stenosed .70%
1 62.1 52.5 67.9
2 24.8 22.1 29.0
3 12.1 9.6 17.5
Unstable angina 51.1 28.9 71.8
CCS class
0 6.9 0.7 21.0
I 9.1 1.4 15.8
II 16.8 7.0 39.1
III 37.1 16.0 64.9
IV 30.1 6.9 49.0
CHF 7.0 4.0 14.7
AMI
None 50.5 50.4 90.3
,24 h 6.0 0.7 12.4
1–7 days 13.6 6.0 28.0
.7 days 31.0 3.0 71.2
IV NTG 26.7 17.9 33.8
Hemodynamically unstable 2.7 2.0 5.8
Cardiogenic shock 0.7 0.2 2.5
Preprocedural IABP/CPS 1.9 0.7 3.5
Acuity
Elective 54.8 35.2 90.5
Urgent 38.9 2.0 57.9
Emergent 6.3 1.2 9.5
VT 2.1 2.1 2.1
Ao valve disease 0.1 0.1 0.4
MR 2.3 0.5 9.0
Diabetes 20.3 13.5 24.0
PVD 7.8 7.0 8.1
Carotid disease 7.3 7.0 8.0
Stroke 5.6 2.6 8.5
Renal failure (dialysis) 0.8 0.2 1.8
HTN 49.2 41.8 63.0
Smoking 34.7 17.5 70.8
COPD 7.6 4.4 11.5
Cholesterol .225 mg/dl 49.9 32.9 57.8
No. of prior PTCA
0 63.0 60.9 100.0
1 26.7 20.2 34.0
.2 10.3 0.0 18.9
Prior heart operation 13.9 3.0 35.6
Prior PTCA same vessel 17.6 0.0 29.6
Lytic Rx within 6 days 7.5 3.9 9.6
PTCA same time as cath 28.0 24.2 34.6
No. of lesions/vessels attempted
1 78.2 56.2 90.4
.2 21.8 9.4 43.8
Table 2. Continued
Variable
Overall
Weighted Mean
Minimum
Site
Maximum
Site
Highest lesion type (ACC/AHA)
A 26.2 11.3 34.6
B 59.1 55.9 68.1
C 14.7 9.2 22.3
LMCA attempted 5.4 0.4 13.0
Vein graft attempted 6.0 0.8 25.3
Thrombus 17.0 15.8 17.2
Lesion length 7.8 7.8 7.8
Ca in lesion 20.4 13.0 25.4
ACC 5 American College of Cardiology; AHA 5 American Heart Associ-
ation; AMI 5 acute myocardial infarction; Ao 5 aortic; Ca 5 calcium; Cath 5
catheterization; CCS 5 Canadian Cardiovascular Society; CHF 5 congestive
heart failure; COPD 5 chronic obstructive pulmonary disease; CPS 5 cardio-
pulmonary support device; HTN 5 hypertension; IABP 5 intraaortic balloon
pump; IV NTG 5 intravenous nitroglycerin; LMCA 5 left main coronary artery
disease; LVEF 5 left ventricular ejection fraction; MR 5 mitral regurgitation;
PTCA 5 percutaneous transluminal coronary angioplasty; PVD 5 peripheral
vascular disease; Rx 5 therapy; VT 5 ventricular tachycardia.
Table 3. Outcomes by Database
Database
In-Hospital
Death (%)
In-Hospital
CABG (%)
Q Wave
MI (%)
NCN 1.3 2.1 1.0
NHLBI 1.4 6.0 —
NACI 1.3 2.4 1.1
NY 0.9 3.2 —
SCAI 0.4 2.2 1.0
Duke 1.1 2.4 —
NNE 1.1 2.8 1.7
CCP 3.5 3.3 1.4
CABG 5 coronary artery bypass graft surgery; MI 5 myocardial infarction;
other abbreviations as in Table 1.
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in the CCP database, reflecting the inclusion of only older
patients in this database.
Univariate predictors of events. Tables 4, 5 and 6 display
the significant univariate predictors of in-hospital death, in-
hospital CABG and in-hospital Q wave MI, respectively. The
tables display the number of sites for which the variable was
tested, the number of databases for which the variable was
significant at the p ,0.05 level and the overall pooled univa-
riable odds ratio and 95% confidence interval around this odds
ratio. We indicate for which variables the test for homogeneity
of risk effect was p , 0.001. In-hospital death had the highest
number of clinical predictors and measures of hemodynamic
instability (e.g., cardiogenic shock and use of an intraaortic
balloon pump) were the most powerful. Measures of disease
severity (such as number of diseased vessels, lesion type, mitral
regurgitation and ejection fraction) were also strong predictors
of mortality. Finally, patient demographics (e.g., age, gender
and body habitus) and a number of comorbid conditions (e.g.,
diabetes, vascular disease and renal function) were also found
to predict in-hospital death.
We also found that the test for homogeneity was significant
for certain variables, indicating that the risk factor predictive
effect varied significantly between individual sites. However,
given our large individual site sample sizes, this test statistic
may be overly sensitive and not indicate clinically meaningful
differences in the predictive power of a risk factor (12).
Although many of these same baseline clinical features also
predicted in-hospital CABG and Q-wave MI (Tables 5 and 6),
these variables tended to be less powerful predictors of these
other end points (i.e., lower odds ratios). In addition, certain
variables that predicted a higher mortality risk (e.g., ejection
fraction) predicted a lower risk for CABG or were not
significant predictors of CABG (e.g., congestive heart failure).
Multivariate predictors of events. Tables 7, 8 and 9 display
the variables chosen in stepwise multivariate analysis by each
database for the three end points. The variables chosen by each
database are organized in the tables into four subgroups for
classification purposes: 1) demographics; 2) coronary disease
severity; 3) comorbidity; 4) catheterization/intervention data.
Table 4. Significant Univariate Predictors of In-Hospital Death
Variable
No. of Sites
Tested
No. of Sites
Signif
Predictor
Pooled Univariable
OR (95% CI)
Age (per 10-yr inc) 8 8 1.84 (1.67–2.02)
Gender (% male) 8 8 0.57 (0.47–0.70)
Height (per 10-cm inc) 7 4 0.85 (0.75–0.90)
Weight (per 10-kg inc)* 7 5 0.79 (0.72–0.89)
LVEF (per 10% dec) 7 7 1.89 (1.79–2.00)
No. of diseased vessels*
2 vs. 1 7 5 1.93 (1.47–2.54)
3 vs. 1 7 7 4.26 (3.09–5.88)
CHF 8 8 4.41 (2.67–7.27)
AMI*
None vs. ,24 hr 5 4 8.34 (5.26–13.22)
None vs. 1–7 days 7 5 2.43 (1.37–4.30)
IV NTG 2 2 3.40 (2.72–4.25)
Hemodynamically unstable 2 2 15.12 (10.26–22.28)
Acuity
Elective vs. urgent 4 3 5.38 (1.33–21.83)
Elective vs. emergent 5 5 8.00 (6.88–9.30)
Cardiogenic shock 4 4 37.88 (25.47–56.34)
Preprocedural IABP/CPS* 5 5 15.19 (9.75–23.70)
VT 2 2 25.23 (8.83–72.15)
MR 2 2 5.97 (4.02–8.87)
Diabetes 8 6 1.83 (1.57–2.14)
PVD 4 4 2.16 (1.78–2.63)
Carotid disease 4 4 1.91 (1.42–2.58)
Stroke* 3 2 4.47 (1.10–18.20)
Renal failure (dialysis) 5 4 5.30 (3.56–7.89)
Creatinine .2.0 mg/dl* 4 4 2.64 (1.32–5.30)
Smoking 6 2 0.69 (0.55–0.87)
Any prior coronary interventions 4 2 0.79 (0.68–0.91)
Prior heart operation 7 4 1.50 (1.22–1.84)
Thrombolytic Rx within 6 days 4 4 1.75 (1.37–2.30)
Highest lesion type (ACC/AHA)
A vs. B 4 2 1.58 (0.97–2.60)
A vs. C 4 3 3.50 (1.83–6.68)
LMCA attempted 5 2 2.56 (1.02–6.44)
Vein graft attempted 4 4 2.75 (2.14–3.53)
Thrombus 3 3 2.87 (1.69–4.88)
*Indicates variables for which the test for homogeneity was p , 0.01,
indicating variability in effect size across individual sites. CI 5 confidence
interval; dec 5 decrease; inc 5 increase; OR 5 odds ratio; Signif 5 significant;
other abbreviations as in Table 2.
Table 5. Significant Univariate Predictors of In-Hospital CABG
Variable
No. of Sites
Tested
No. of Sites
Signif
Predictor
Pooled
Univariable OR
(95% CI)
LVEF (per 10 inc) 6 2 0.90 (0.82–0.99)
CCS class
1 vs. 2 3 1 0.67 (0.53–0.83)
1 vs. 3 4 1 0.84 (0.63–1.12)
1 vs. 4 4 3 0.84 (0.40–1.43)
AMI
None vs. ,24 h 4 3 2.15 (1.57–2.95)
None vs. 1–7 days 3 1 1.22 (1.03–1.43)
IV NTG 1 1 1.76 (1.46–2.12)
Hemodynamically unstable 2 2 6.67 (4.56–9.74)
Acuity
Elective vs. urgent 3 2 1.37 (1.17–1.61)
Elective vs. emergent 2 1 5.82 (4.88–6.93)
Cardiogenic shock 4 3 4.72 (2.47–9.00)
Preprocedural IABP/CPS 3 3 9.12 (4.06–20.50)
VT 1 1 2.05 (1.35–3.13)
MR 2 2 (pooled) 1.38 (1.03–1.85)
COPD 4 1 1.36 (1.16–1.60)
Cholesterol .225 mg/dl 2 1 0.78 (0.69–0.90)
Any prior coronary interventions 3 2 0.66 (0.58–0.74)
Prior heart operation 6 5 0.59 (0.42–0.83)
Prior intervention, same vessel 1 1 0.35 (0.18–0.66)
Highest lesion type (ACC/AHA)
A vs. B 2 1 1.66 (1.18–2.34)
A vs. C 2 1 3.20 (2.19–4.66)
Calcium in attempted lesion 2 1 1.65 (1.21–2.27)
Abbreviations as in Tables 2 and 4.
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There was a high degree of consistency in the significant
multivariate predictors of outcomes across the databases, as
was noted in the univariate analysis.
Although the attempt of this analysis was not to develop the
ideal predictive instrument, we did ask the databases to report
the discrimination abilities of their final stepwise multivariate
models (in terms of the area under the receiver operating
characteristics curve or C-index). For in-hospital death, all
databases were able to discriminate which patients were likely
to live from those who were likely to die, the C-index for
in-hospital mortality ranging from 0.79 to 0.93. The models
using variables for CABG within the same hospital period and
Q wave MI were less robust, with CABG model C-indexes of
0.60 to 0.70 and Q wave MI model C-indexes of 0.60 to 0.69.
Variable selection. These data were then used to select the
most important prognostic variables for coronary interven-
tional outcomes. This comparison process provided a list of 29
variables that demonstrated an odds ratio .2.0 (or ,0.5) in
$50% of the databases in the univariate analysis or were a
significant predictor identified in a majority of the multivariate
analyses. The variables were divided into the categories of
demographics, heart disease severity, acuity, comorbidity and
procedure details. Consensus definitions for these variables are
provided in Table 10.
Discussion
Selection of variables. This report presents guidelines for a
data-supported minimum set of variables required to risk
stratify patients undergoing catheter based coronary interven-
tions that could be incorporated into all interventional data-
bases. A uniform minimum dataset, permitting risk adjustment
of performance could thus be recorded by any institution,
permitting simple responses to requests for information and
comparisons between databases. For any database, the actual
selection of variables is problematic and is closely related to
the goals of data collection. Databases can be used for other
analyses (e.g., process measures, cost) that demand collection
of other variables. The purpose of the present study was to
strictly limit the variables to those which actually provide risk
information. Completely objective definitions limit “gaming”
but are not possible for all variables. Thus, in multi-
institutional databases some form of auditing will likely be
needed to allow consistent interpretation of data across insti-
tutions. It is also important that the variable is reproducible.
Table 6. Significant Univariate Predictors of In-Hospital Q Wave
Myocardial Infarction
Variable
No. of Sites
Tested
No. of Sites
Signif
Predictor
Pooled Univariable
OR (95% CI)
Age (per 10-yr inc) 4 2 1.12 (1.05–1.19)
No. of diseased vessels
2 vs. 1 3 3 1.35 (1.15–1.58)
3 vs. 1 3 2 1.88 (1.59–2.23)
Unstable angina 3 2 1.86 (1.57–2.20)
AMI*
None vs. ,24 h 3 2 1.55 (1.04–2.31)
None vs. 1–7 days 2 1 1.29 (1.02–1.63)
IV NTG 1 1 1.84 (1.49–2.27)
Hemodynamically unstable 1 1 4.78 (2.30–10.00)
Acuity
Elective vs. urgent 4 2 1.43 (1.16–1.76)
Elective vs. emergent 3 3 3.07 (2.11–4.45)
Cardiogenic shock 1 1 2.85 (1.02–7.95)
Preprocedural IABP/CPS 3 3 4.19 (2.52–6.95)
MR 1 1 4.36 (2.02–9.41)
Stroke 4 2 1.45 (1.17–1.79)
Prior heart operation 4 3 1.60 (1.21–2.13)
Prior intervention, same vessel 2 2 0.55 (0.42–0.72)
Thrombolytic Rx within 6 days 1 1 1.27 (1.02–1.57)
.2 lesions/vessels attempted 3 1 1.51 (1.23–1.85)
Highest lesion type (ACC/AHA)
A vs. B 2 1 1.62 (1.30–2.01)
A vs. C 2 1 2.23 (1.65–3.01)
Vein graft attempted 2 1 1.91 (1.42–2.58)
Thrombus 2 2 2.01 (1.40–2.89)
*Indicates variables for which the test for homogeneity was p , 0.01,
indicating variability in effect size across individual sites. Abbreviations as in
Tables 2 and 4.
Table 7. Variables Chosen in Stepwise Procedure by Site (in-
hospital death)
NCN NHLBI NACI NY SCAI Duke NNE CCP
Demographics
Age 3 3 3 3 3 3 3 3
Gender 3 3 3
Height 3 3
Weight 3
CAD severity
LVEF 3 3 3 3 3
No. of diseased
vessels
3 3 3 3 3
Unstable angina 3 3 3
CCS class 3 3 3
CHF 3 3 3 3 3 3 3
AMI 3 3 3 3
Hemodynamically
unstable
3 3
Acuity 3 3 3 3 3
Cardiogenic
shock
3 3 3 3 3
IABP 3 3 3
VT 3
Comorbidity
Diabetes 3 3 3 3 3
MR 3 3
PVD 3 3
Renal failure 3 3 3 3 3
HTN 3
Interventional Hx
Same-vessel
intervention
3 3
Lesion type 3 3
LMCA attempt 3
Graft attempt 3 3
Thrombus 3 3
CAD 5 coronary artery disease; Hx 5 history; other abbreviations as in
Tables 1 and 2.
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For example, although lesion characteristics appear to be
predictive in individual databases, Botas et al. (16), using
Bypass Angioplasty Revascularization Investigation (BARI)
data showed that reproducibility of readings by core laboratory
interpreters was unacceptable for features such as tortuosity,
eccentricity, discrete, diffuse or tubular lesions or calcification.
End points. Another problem is the choice of end points.
Adverse outcomes are relatively few (3), so there is a desire to
increase the end points, thus improving the robustness of any
model by combining several outcomes. Usually, in-hospital
mortality, emergency CABG and Q wave infarctions are
combined. However, this study points out that individual
variables may have interactions opposite in direction to the
individual end points, so that their important role is not
apparent. This is seen in the case of the variables “depressed
ejection fraction” and “percutaneous transluminal coronary
angioplasty (PTCA) of a graft,” which were associated with
increased in-hospital death but not associated with in-hospital
CABG.
Definition of end points. The methods used to define the
end points chosen for analysis deserve comment. Short-term
mortality is defined as “in-hospital death.” “Death within 30
days of an intervention” may be better but is at present
impractical because of difficulty in obtaining outpatient
follow-up information. “All-cause mortality” is not gameable
and was therefore chosen. This minimum data set for coronary
interventional procedures is not meant to be predictive for all
patients undergoing all types of coronary interventional pro-
cedures. However, as much as possible we attempted to remain
congruent with definitions chosen for CABG (10) so that if
outcomes by patient characteristics were compared, data
would be available.
Which variables best predict outcome? It should be em-
phasized that we intended to identify a minimum dataset for
catheter-based interventional cardiology outcomes. Data ele-
ments that reflect longer term effects on cardiac disease (e.g.,
hypertension, lipid profile, family history) are important in any
database where the intent is to evaluate longer term outcomes.
We realize that other variables that were not tested in this
report may be equally predictive of short-term outcomes. The
American College of Cardiology database includes our mini-
mum data elements and is an example of a larger, more
comprehensive database that might be used to evaluate both
short-term and longer range outcomes (17).
Limitations of the study. By necessity, the data on the
variables included in this report were retrospectively gathered.
Existing variable definitions were matched as closely as possi-
ble to the consensus variable definitions. However, our pooled
Table 8. Variables Chosen in Stepwise Procedure by Site (in-
hospital coronary artery bypass graft surgery)
NCN NHLBI NACI NY SCAI Duke NNE CCP
Demographics
Age 3 3
Gender 3
Weight 3 3
CAD severity
LVEF 3 3
No. of diseased
vessels
3 3 3 3 3 3
Unstable
angina
3 3 3
CCS class 3 3 3
CHF 3 3
AMI 3 3
Prior MI 3
IV NTG 3
Hemodynamically
unstable
3
Acuity 3 3
IABP 3 3 3
Comorbidity
Diabetes 3 3 3 3 3
PVD 3
COPD 3
Stroke 3
Renal failure 3
Smoking 3
High
cholesterol
3
Intervention Hx
No. of prior
interventions
3 3 3
Prior heart
operation
3 3 3 3 3 3
Same vessel 3
No. of lesions
attempted
3 3
Lesion type 3 3 3
Graft attempt 3 3
Lesion Ca 3
Abbreviations as in Tables 1, 2 and 7.
Table 9. Variables Chosen in Stepwise Procedure by Site (Q wave
myocardial infarction)
NCN NACI SCAI NNE CCP
Demographics
Weight 3
CAD Severity
Unstable angina 3 3
CCS Class 3
AMI 3
Prior MI 3
IABP 3 3
Comorbidity
MR 3
Carotid disease 3
Smoking 3
Intervention Hx
No. of prior interventions 3
Prior heart operation 3 3 3
Intervention same vessel 3
No. of lesions attempted 3
Thrombus 3 3
MI 5 myocardial infarction; other abbreviations as in Tables 1, 2 and 7.
280 BLOCK ET AL. JACC Vol. 32, No. 1
MINIMUM DATASET FOR CORONARY INTERVENTIONS July 1998:275–82
Table 10. Variables Related to In-Hospital Adverse Outcomes*
Demographics
Age Date of birth as stated by patient or family
Gender Male; female
Heart disease severity
LVEF
Calculated—% Calculated by LV gram, echo, blood pool scan
Estimated—% Estimated by LV gram, echo, blood pool scan
No. of vessels .70% By angiography measured, quantified or estimated diameter stenosis; “vessel” defined as
RCA and its branches, proximal LAD (before 1st diagonal) mid/distal LAD and its
branches and Cx and its branches
Unstable angina Progressive or new onset or occurs at rest accompanied by ECG changes, hypotension
or pulmonary congestion
CCS class IV Highest CCS angina class leading to hospital admission and/or intervention; 0 5 no
angina by Hx
CHF Hx of CHF before intervention
,24 h AMI Within 24 h of AMI
1–7 days after AMI .1 day; ,7 days of AMI
Acuity/hemodynamic variables
Urgency (urgent/emergent) Elective: patient clinically stable; procedure routinely scheduled
Urgent: unstable patient; procedure scheduled before discharge
Emergent/ongoing ischemia: ongoing ischemia including rest angina despite maximal
therapy (medical or IABP)
Emergent/hemodynamic instability: shock, with or without hemodynamic support
Emergent/salvage: arrest with CPR immediately before entering lab
Cardiogenic shock Hypoperfusion with SBP ,80 mm Hg and central filling pressure .20 mm Hg or
cardiac index ,1.8 liters/min per m2; also present if inotropes or IABP needed to
maintain these values
Preprocedural IABP/CPS IABP/CPS assist device placed before intervention
Comorbidity
Ao disease Ao valve area ,1.0 cm2 and/or Ao regurgitation .21
MR .21 Presence of mitral regurgitation .21
Diabetes (treated) Clinical diagnosis of diabetes treated either with oral agents or insulin with or without
sequelae
PVD Presence of occlusive disease in the aorta, iliac or femoral artery sufficient to cause
symptoms
Stroke Hx of/presence of fixed neurologic deficit
Renal failure
Creatinine If creatinine preintervention known, list creatinine
Creatinine .2 mg/dl Creatinine .2 mg/dl known in past
Dialysis Patient on dialysis
Cholesterol .225 mg/dl (reduced risk) Measured cholesterol .225 mg/dl before intervention
Technical considerations
Same vessel intervention (reduced risk) Any previous intervention on same vessel
Type C lesion attempted Type A: concentric, noncalcified, .3 mm in length, not at bifurcation or angulated.
Type C: total occlusion. Type B: all others (ACC/AHA)
LMCA attempted
Unprotected Intervention involving all or part of LMCA
Protected “Protected” LMCA stenosis by patent bypass conduit
Vein graft intervention Any intervention to SVG or IMA
Thrombus Intraluminal filling defect, haziness or contrast staining in artery before intervention
Other variables with OR .2.0 but not independent predictors
of in-hospital outcomes on multivariate logistic analyses
IV NTG Use of preinterventional IV NTG
Unstable hemodynamic variables Need for preinterventional IV pressors
VT VT needing pharmacologic Rx or cardioversion
Carotid disease Presence of .70% carotid stenosis by ultrasound or angiography
*More than 50% of databases that evaluated the variable showed an odds ratio .2.0 or variable chosen on multivariable analysis. CPR 5 cardiopulmonary
resuscitation; Cx 5 circumflex coronary artery; ECG 5 electrocardiographic; Echo 5 echocardiography; IMA 5 internal mammary artery; lab 5 laboratory; LAD 5
left anterior descending coronary artery; LV gram 5 left ventriculogram; SVG 5 saphenous vein graft; other abbreviations as in Table 2.
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estimates of a specific variable’s effect size should be consid-
ered only as a relative approximation because this effect varied
somewhat across individual sites for certain variables. In
addition, some important variables, such as jeopardy score (18)
or lesion characteristics defined by coronary ultrasound, were
not included because they were not available in the databases
surveyed. The data were also collected at various times, and
most data were collected before the introduction of the new
atherectomy devices, stents, and glycoprotein IIb/IIIA platelet
receptor antagonists, which may have a significant impact on
the importance of lesion specific variables (e.g., thrombus,
eccentricity). We used data that predominantly referred to
PTCA. As new devices are used, device-specific risk factors
may be identified. Some variables amenable to gaming had to
be included because of their predictive power (1). In some
respects trying to control for gaming may seem “unfairly
harsh” in some instances (e.g., in-hospital CABG includes all
same-admission CABG, even elective), and even the broad
definition of in-hospital death will obviously include some
patients with a nonprocedure-related death. We only analyzed
variables predicting adverse outcomes and do not imply that
databases should be limited to that end point only.
Summary. By analyzing interventional outcomes across
several large cardiac databases we were able to select 29
variables that had the strongest statistical association with
outcomes. The variables selected are generally objective, easily
obtainable and definable. Incorporation of these elements in
every cardiac dataset will permit laboratories to be able to
provide the information required in this era of managed care
and preferred provider contracts as well as permit comparisons
of the outcome of coronary interventions.
References
1. Ellis SG, Omoigui N, Bittl JA, et al. Analysis and comparison of operator-
specific outcomes in interventional cardiology: from a multicenter database
of 4860 quality-controlled procedures. Circulation 1996;93:431–9.
2. Kassirer JP. The use and abuse of practice profiles. N Engl J Med
1994;330:634–6.
3. Lindsay JJ, Pinnow EE, Popma JJ, Pichard AD. Obstacles to outcomes
analysis in percutaneous transluminal coronary revascularization. Am J
Cardiol 1995;76:168–72.
4. Ellis SG, Topol EJ, Gallison L, et al. Predictors of success for coronary
angioplasty performed for acute myocardial infarction. J Am Coll Cardiol
1988;12:1407–15.
5. Kimmel SE, Berlin JB, Strom BL, Laskey WK, for the Registry Committee
of the Society for Cardiac Angiography and Interventions. Development and
validation of a simplified predictive index for major complications in
contemporary percutaneous transluminal coronary angioplasty practice.
J Am Coll Cardiol 1995;26:931–8.
6. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty: statewide experi-
ence in California. Circulation 1993;88:2735–43.
7. Hannan EL, Arani DT, Johnson LW, Kemp HG Jr, Lukacik G. Percutane-
ous transluminal coronary angioplasty in New York State; risk factors and
outcomes. JAMA 1992;268:3092–7.
8. Bergelson BA, Jacobs AK, Cupples LA, et al. Prediction of risk for
hemodynamic compromise during percutaneous transluminal coronary an-
gioplasty. Am J Cardiol 1992;70:1540–5.
9. O’Connor GT, Malenka DJ, Robb JG, et al. Differences in outcomes
between women and men associated with percutaneous transluminal coro-
nary angioplasty: a regional perspective study of 13,061 procedures. Circu-
lation 1996;94 Suppl II:II-99–104.
10. Jones RH, Hannan EL, Hammermeister KE, DeLong ER, O’Connor GT,
Luepker RV, et al. Identification of pre-operative variables needed for risk
adjustment of short-term mortality after coronary artery bypass graft surgery.
J Am Coll Cardiol 1996;28:1478–87.
11. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Explora-
tion of the precision of classifying sudden cardiac death: implications for the
interpretation of clinical trials. Circulation 1996;93:519–24.
12. Hedges LR, Olkin I. Statistical Methods for Meta-Analysis. Orlando (FL):
Academic Press, 1985:22–130.
13. Hasselblad V, McCrory DC. Meta-analytic tools for medical decision
making: a practical guide. Med Decis Making 1995;15:81–96.
14. Eddy DM, Hasselblad C, Schachter R. An introduction to a Bayesian
method for meta-analysis: the confidence profile method. Med Decis Making
1990;10:15–23.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver
operating characteristic (ROC) curve. Radiology 1982;143:29–36.
16. Botas J, Stadius ML, Bourassa MG, et al. Angiographic correlates of lesion
relevance and suitability for percutaneous transluminal coronary angioplasty
and coronary artery bypass grafting in the Bypass Angioplasty Revascular-
ization Investigation study (BARI). Am J Cardiol 1996;77:805–14.
17. Weintraub WS, McKay CR, Riner R, et al. The American College of
Cardiology National Database: progress and challenges. J Am Coll Cardiol
1997;29:459–65.
18. Ryan TJ, Bauman WB, Kennedy JW, et al. ACC/AHA guidelines for
percutaneous transluminal coronary angioplasty: a report of the American
College of Cardiology/American Heart Association Task Force on Assess-
ment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee
on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol
1993;22:2033–54.
282 BLOCK ET AL. JACC Vol. 32, No. 1
MINIMUM DATASET FOR CORONARY INTERVENTIONS July 1998:275–82
